To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
Inke is attending Inhalation Asia 2019 in Hong Kong on the 13th – 15th November. The once every two years exhibition will take place at the Hong Kong Science and Technology Park, in Sha Tin.